Clinical Evaluation of Ropinirole CR-RLS Tablets in Restless Legs Syndrome-Open-Label, Uncontrolled Study. Classification: Clinical Pharmacology, Exploratory
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2018
At a glance
- Drugs Ropinirole (Primary)
- Indications Restless legs syndrome
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 21 Aug 2009 Planned number of patients changed from 30 to 35 as reported by ClinicalTrials.gov.
- 15 Oct 2008 Actual start date changed from Jul 2007 to Aug 2007 as reported by ClinicalTrials.gov.